Cision PR Newswire

Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China’s 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products

SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...

Innovative Immunology Biotech Windward Bio Lists on Nasdaq

SHANGHAI, Nov. 14, 2026 /PRNewswire/ -- Windward Bio, a portfolio company of Qiming Venture...

WeFetch AI Corp. Is the New Name of GreenCore Solutions Corp.

gtinfetch.ai, WeFetch.ai's lead product, removes the guess from artificial intelligence (AI) shopping: the right...

iGreen Think Tank Releases Independent ESG Research, Highlighting China Overseas Land & Investment Ltd.’s Verified Low-Carbon and Governance Performance

SHENZHEN, China, Dec. 16, 2025 /PRNewswire/ -- iGreen Think Tank, an independent research institution specializing in sustainable development and ESG evaluation, has released its latest...

Luda Technology Group Limited (LUD.US) Reports Significant Gains from Strategic Equity Investment Portfolio for Eleven Months Ended November 30, 2025

HONG KONG, Dec. 16, 2025 /PRNewswire/ -- Luda Technology Group Limited and its subsidiaries ("Luda Technology" or the "Company", NYSE: LUD.US) announced that its strategic equity investment...

GDIN’s Global Pilot Program Demonstrates the Real-World Impact of K-Digital Innovation

SEOUL, SOUTH KOREA, Dec. 16, 2025 /PRNewswire/ -- The Global Digital Innovation Network (GDIN), in collaboration with the Ministry of Science and ICT (MSIT)...